Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Abavisani

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Annals of Clinical Microbiology and Antimicrobials|August 10, 2023
Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysisMohammad Abavisani, Masoud Keikha
New Microbes and New Infections|September 18, 2023
Comments on "Disseminated <i>Nocardia transvalensis complex</i> and <i>farcinica</i>: First case in an immunocompetent"Mohammad Abavisani, Jalil Rouhani, Masoud Keikha
International Journal of Surgery (London, England)|June 15, 2023
A commentary on emergency surgery in the era of artificial intelligence: ChatGPT could be the doctor's right-hand manMohammad Abavisani, Farhad Dadgar, Masoud Keikha
BMC Infectious Diseases|January 15, 2024
First global report about the prevalence of multi-drug resistant Haemophilus influenzae: a systematic review and meta-analysisMohammad Abavisani, Masoud Keikha, Mohsen Karbalaei
Current Drug Targets|November 10, 2023
Common Clinical Features of Cases with Mpox ReinfectionMasoud Keikha, Mohammad Abavisani, Amirhossein Sahebkar
Drug Discovery Today|February 2, 2024
Artificial intelligence in drug discovery: A new frontier in the fight against Mycobacterium tuberculosisMohammad Abavisani, Alireza Khoshrou, Amirhossein Sahebkar
Journal of Drug Targeting|May 19, 2025
Microbiome-driven precision medicine: advancing drug development with pharmacomicrobiomicsNegar Ebadpour, Mohammad Abavisani, Amirhossein Sahebkar
Drug Discovery Today|October 11, 2024
The Wnt signaling cascade: a potential but untapped therapeutic target for monkeypox infectionNavid Faraji, Mohammad Abavisani, Amirhossein Sahebkar
Clinical and Experimental Vaccine Research|November 11, 2024
How does geographical diversity shape vaccine efficacy?Mohammad Abavisani, Bahareh Ansari, Negar Ebadpour, et al.
Molecular Neurobiology|September 23, 2024
Unlocking Hope: Therapeutic Advances and Approaches in Modulating the Wnt Pathway for Neurodegenerative DiseasesNavid Faraji, Negar Ebadpour, Mohammad Abavisani, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Annals of Clinical Microbiology and Antimicrobials|August 10, 2023
Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysisMohammad Abavisani, Masoud Keikha
New Microbes and New Infections|September 18, 2023
Comments on "Disseminated <i>Nocardia transvalensis complex</i> and <i>farcinica</i>: First case in an immunocompetent"Mohammad Abavisani, Jalil Rouhani, Masoud Keikha
International Journal of Surgery (London, England)|June 15, 2023
A commentary on emergency surgery in the era of artificial intelligence: ChatGPT could be the doctor's right-hand manMohammad Abavisani, Farhad Dadgar, Masoud Keikha
BMC Infectious Diseases|January 15, 2024
First global report about the prevalence of multi-drug resistant Haemophilus influenzae: a systematic review and meta-analysisMohammad Abavisani, Masoud Keikha, Mohsen Karbalaei
Current Drug Targets|November 10, 2023
Common Clinical Features of Cases with Mpox ReinfectionMasoud Keikha, Mohammad Abavisani, Amirhossein Sahebkar
Drug Discovery Today|February 2, 2024
Artificial intelligence in drug discovery: A new frontier in the fight against Mycobacterium tuberculosisMohammad Abavisani, Alireza Khoshrou, Amirhossein Sahebkar
Journal of Drug Targeting|May 19, 2025
Microbiome-driven precision medicine: advancing drug development with pharmacomicrobiomicsNegar Ebadpour, Mohammad Abavisani, Amirhossein Sahebkar
Drug Discovery Today|October 11, 2024
The Wnt signaling cascade: a potential but untapped therapeutic target for monkeypox infectionNavid Faraji, Mohammad Abavisani, Amirhossein Sahebkar
Clinical and Experimental Vaccine Research|November 11, 2024
How does geographical diversity shape vaccine efficacy?Mohammad Abavisani, Bahareh Ansari, Negar Ebadpour, et al.
Molecular Neurobiology|September 23, 2024
Unlocking Hope: Therapeutic Advances and Approaches in Modulating the Wnt Pathway for Neurodegenerative DiseasesNavid Faraji, Negar Ebadpour, Mohammad Abavisani, et al.
Pageof 4